Sepsis Diagnostics Market Statistics 2021 : Growth, Forecast and Competitive Analysis

Sepsis is a life-threatening medical emergency. It is body's response to infection that may lead to a systemic inflammatory reaction, tissue damage, and ultimately organ dysfunction and/or failure.
 
BRUSSELS - Aug. 8, 2022 - PRLog -- Sepsis is a life-threatening medical emergency. It is body's response to infection that may lead to a systemic inflammatory reaction, tissue damage, and ultimately organ dysfunction and/or failure.

As per WHO, globally, sepsis touches around 49 million people each year. Early diagnosis of sepsis is serious for patient outcomes. However, diagnosing sepsis is not an easy task as there is no particular symptom or sign that are directly related to the disease.

Growth of Rapid Diagnostic Tests/Point-of-Care Techniques Set to Drive the Sepsis Diagnostics Market
Currently, clinicians possess limited technology needed to conduct multiplexed and fully quantitative diagnostic tests at the point of care with high sensitivity. Citing the need for rapid diagnostic tests, several research universities and product manufacturers are developing innovative rapid diagnostic tests/point-of-care techniques.

For instance,
  • Researchers at the University of Strathclyde have developed an innovative, low cost test for early diagnosis of sepsis. The experimental device analyzes patient's blood and provides results in just 2.5 minutes compared to current testing methods for sepsis which takes up to 72 hours.

"With sepsis, timing is the key. Advancements in diagnostic speed, range, and accuracy are critical for addressing the continued rise in sepsis cases and deaths. Advent of new rapid diagnostic tests for sepsis can save thousands of lives." - Senior Director, Leading In-Vitro Diagnostics Manufacturer, United States

Get Customized Report on Sepsis Diagnostics Market @ https://meditechinsights.com/sepsis-diagnostics-market/

Competitive Landscape Analysis: Sepsis Diagnostics Market

The Sepsis Diagnostics market is marked by presence of both established players such as bioMérieux, Becton, Dickinson and Company, Thermo Fisher Scientific, Danaher Corporation and innovative firms such as Seegene Inc., Axis-Shield Diagnostics, Immunexpress, and others.

For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights:


Medi-Tech Insights is a healthcare-focused business research & insights firm. We have successfully completed 100+ projects in Healthcare IT, MedTech, Medical Devices & Pharma Services in the areas of due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry leading CXO, VPs and key demand/supply side decision-makers.

Contact Us:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com

Media Contact
Tejashri Khade
tejashri.k@meditechinsights.com
0498868079
End
Email:***@meditechinsights.com Email Verified
Tags:Sepsis Diagnostics Market
Industry:Health
Location:Brussels - Brussels - Belgium
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Meditech insights News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share